| | Closure of Trading Window | 26/12/23 12:44 | Insider Trading / SAST |  |
| | Pursuant to SEBI (PIT) Regulations, 2015, the Trading Window shall remain closed from the close of business hours of Friday, 29th December 2023 till 48 hours after the declaration of Unaudited Financial Results for the third quarter and nine months ended 31st December 2023. | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 22/12/23 18:11 | | |
| | PFA intimation w.r.t issue of duplicate share certificate | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 19/12/23 10:53 | | |
| | PFA intimation w.r.t loss of share certificates | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 24/11/23 11:17 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 23, 2023 for Ravi Agrawal, trustee Ravi Agrawal Trust | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 22/11/23 09:48 | | |
| | PFA herewith intimation w.r.t loss of share certificates | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 07/11/23 16:58 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 07, 2023 for Aayush Agrawal, trustee Aayush Agrawal Trust | |
| |
| | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | 03/11/23 12:15 | Company Update | |
| | PFA herewith Written Transcript of Earnings Call held on 31st October 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 01/11/23 12:48 | Company Update | |
| | Pursuant to Regulation 47 of the Listing Regulations, please find enclosed copies of financial results of the Company for the quarter ended 30th September 2023 published in the following newspapers on 1st November 2023:
1. Mumbai edition of Business Standard and
2. Mumbai edition of Navakal | |
| |
| | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 09/10/23 16:16 | Company Update | |
| | Please find enclosed certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2023. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 30/09/23 15:48 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 30, 2023 for Aayush Agrawal, trustee Aayush Agrawal Trust | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 29/09/23 16:19 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 29, 2023 for Ravi Agrawal, trustee Ravi Agrawal Trust | |
| |
| | Closure of Trading Window | 28/09/23 16:24 | Insider Trading / SAST | |
| | Pursuant to provisions of SEBI (PIT) Regulations, 2015 as amended from time to time, trading window shall be closed from the close of business hours of Saturday, 30th September 2023 till 48 hours after the declaration of the financial results of the Company. | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 27/09/23 09:52 | | |
| | PFA herewith intimation w.r.t loss of share certificates | |
| |
| | Business Responsibility and Sustainability Reporting (BRSR) | 21/09/23 14:45 | | |
| | PFA herewith BRSR for FY 2023. | |
| |
| | Reply To Clarification Sought By BSE | 15/09/23 12:41 | Company Update | |
| | Pl. find attached herewith Company''s reply w.r.t. clarification sought by BSE. | |
| |
| | Clarification sought from Ajanta Pharma Ltd | 14/09/23 11:52 | Company Update | |
| | The Exchange has sought clarification from Ajanta Pharma Ltd on September 14, 2023, with reference to Movement in Volume.
The reply is awaited. | |
| |
| | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | 09/08/23 16:42 | Insider Trading / SAST | |
| | The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund & PACs | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 07/08/23 11:13 | | |
| | Issue of Letter of confirmation in lieu of duplicate share certificate | |
| |
| | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | 02/08/23 17:23 | Company Update | |
| | PFA herewith written transcript of earnings call held on 27th July 2023. | |
| |
| | Record Date For Dividend | 28/07/23 12:29 | Corp. Action | |
| | Board fixes Friday, 4th August 2023 as record date. | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 28/07/23 12:21 | | |
| | Intimation regarding issue of letter of confirmation in lieu of duplicate share certificate | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 28/07/23 12:18 | Company Update | |
| | PFA herewith results published in Business Standard & Navakal. | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | 27/07/23 19:04 | Company Update | |
| | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 27th July 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link:
https://ajantapharma.com//images/EarningsAudioQ1-2023-24.mp3
Written transcript of the same will be submitted in due course. | |
| |
| | Grant Of Options | 27/07/23 18:18 | Company Update | |
| | Nomination & Remuneration Committee meeting has at its meeting held today granted 76,350 options. | |
| |
| | Corporate Action-Board approves Dividend | 27/07/23 16:29 | Corp. Action | |
| | Pursuant to Reg. 42 of SEBI LODR, the record date for the purpose of determination of dividend has been fixed as Friday, 4th August 2023 | |
| |
| | Corporate Action-Board approves Dividend | 27/07/23 16:12 | Corp. Action | |
| | Board had at their meeting held today considered and approved:
1. 1st interim dividend of Rs. 315 cr for FY 2024. It translates into Rs. 25 per share (1250%) on face-value of Rs. 2/- per share.
Total dividend of Rs. 25 per share includes a regular dividend of Rs. 10 per share and an additional Rs. 15 per share, distributed as a special dividend on the commemoration of 50 years of momentous journey of the Company.
2. Fixed Friday, 4th August .... | |
| |
| | Financial Results For Quarter Ended 30Th June 2023 | 27/07/23 15:59 | Result | |
| | Enclosed Financial results for quarter ended 30th June 2023. | |
| |
| | Board Meeting Outcome for Outcome Of Board Meeting | 27/07/23 15:52 | Board Meeting | |
| | Outcome of Board Meeting | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 24/07/23 14:56 | | |
| | PFA herewith intimation w.r.t. loss of share certificates. | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 24/07/23 11:26 | Company Update | |
| | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 27th July 2023, post Board meeting. | |
| |
| | Corporate Action-Board to consider Dividend | 24/07/23 11:21 | Corp. Action | |
| | Board to consider interim dividend at the meeting held on Thursday, 27th July 2023. | |
| |
| | Update on board meeting | 24/07/23 11:19 | Board Meeting | |
| | AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve This is with reference to our letter dated 14th July 2023, informing you about the Board meeting scheduled on Thursday, 27th July 2023 to inter-alia consider and take on record the unaudited financial results for the first quarter ended 30th June 2023.
Pursuant to Regulation 29(1)(e) of Listing .... | |
| |
| | Disclosure Under Regulation 30 Of LODR | 21/07/23 11:00 | Company Update | |
| | Please find attached herewith letter which is self-explanatory. | |
| |
| | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | 18/07/23 15:59 | AGM/EGM | |
| | Pursuant to Regulation 44 of LODR, we submit herewith the following:
a. Details of voting results on each resolution set out in the notice and
b. Consolidated Scrutinizers'' report dated 18th July 2023. | |
| |
| | Announcement under Regulation 30 (LODR)-Meeting Updates | 18/07/23 15:55 | Company Update | |
| | Please find enclosed herewith proceedings of Annual General Meeting held on 18th July 2023 through VC/OAVM. | |
| |
| | Board Meeting Intimation for Considering And Approving Quarterly Results | 14/07/23 17:50 | Board Meeting | |
| | AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2023. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 30/06/23 16:12 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 30, 2023 for Ravi Agrawal, trustee Ravi Agrawal Trust | |
| |
| | Closure of Trading Window | 30/06/23 14:21 | Insider Trading / SAST | |
| | Pursuant to provisions of SEBI (PIT) Regulations, 2015 as amended from time to time, trading window shall be closed from the close of business hour of Friday, 30th June 2023 till 48 hours after the declaration of financial results of the Company. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 30/06/23 11:53 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 29, 2023 for Aayush Agrawal, trustee Aayush Agrawal Trust | |
| |
| | US FDA Inspection Of Our Dahej Facility | 26/06/23 07:37 | Company Update | |
| | This is to inform you that our formulation facility at Dahej was inspected by US FDA from 19th June 2023 to 23rd June 2023.
At the end of inspection, no Form 483 was issued to us. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 23/06/23 14:01 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 23, 2023 for Ravi Agrawal, trustee Ravi Agrawal Trust | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 19/06/23 09:37 | Company Update | |
| | Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers regarding e-voting information for the 44th Annual General Meeting of the Company in terms of Section 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and
Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the following newspapers .... | |
| |
| | Notice Of The 44Th Annual General Meeting (AGM) & Annual Report 2022-23 | 16/06/23 12:41 | Company Update | |
| | In compliance with the Companies Act 2013, rules framed thereunder and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed Notice convening the 44th AGM of shareholders and the Annual Report 2022-23 | |
| |
| | Reg. 34 (1) Annual Report. | 16/06/23 12:36 | | |
| | We hereby inform that the Forty-Fourth Annual General Meeting ('AGM') of the Company will be held on Tuesday, 18th July 2023 at 11.00 a.m. through Video Conferencing or Other Audio-Visual Means.
Pursuant to Regulation 34(1) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report and Business Responsibility & Sustainability Report of the Company for .... | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 14/06/23 11:51 | Company Update | |
| | Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers in terms of Circular No. 20/2020 dated 5th May 2020 issued by Ministry of Corporate Affairs, inter-alia, intimating that 44th Annual General Meeting of the Company will be held on 18th July 2023 through Video Conferencing/Other Audio-Visual Means, in the following newspapers: a) Mumbai edition of Free Press Journal; b) Mumbai edition of Navshakti. | |
| |
| | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | 01/06/23 14:57 | | |
| | Pursuant to Regulation 39(3) and other applicable regulations of SEBI Listing Regulations, we would like to inform you that Registrar and Transfer Agent of Company, M/s. Link Intime India Private Limited has received intimation for loss of share certificate and request for issuance of duplicate share certificate from a Shareholder. | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 19/05/23 17:44 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 19, 2023 for UMIL Share & Stock Broking Services Ltd | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 19/05/23 17:43 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 19, 2023 for Brij Investments Pvt Ltd | |
| |
| | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | 19/05/23 17:22 | Insider Trading / SAST | |
| | The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 19, 2023 for Aayush Agrawal, trustee Aayush Agrawal Trust | |
| |
| | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | 11/05/23 12:09 | Company Update | |
| | Further to our communication dated 5th May 2023 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 5th May 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link https://ajantapharma.com//images/EarningsCallTranscriptQ4(Jan-Mar)2022-23.pdf. | |
| |